Helus Pharma (R7E.F) Q4 2024 Earnings

13NovConfirmed
Q4 2024
-2
-1.34
-0.68
-0.02

Details

Expected EPS
-0.024487017555
Actual EPS
-2.0009391487799997
Surprise EPS
-1.98
Surprise Percent
+8,071.43%

Description

Helus Pharma (R7E.F) has reported earnings of -2.0009391487799997 per share for Q4 2024.

0 Comments

Share your thoughts